首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Inhibition of invasion by N-trans-feruloyloctopamine via AKT,p38MAPK and EMT related signals in hepatocellular carcinoma cells
Authors:Zhong-Tian Bai  Zheng-Rong Wu  Li-Li Xi  Xun Li  Peng Chen  Fu-Qiang Wang  Wen-Bo Meng  Wen-Ce Zhou  Xin-An Wu  Xiao-Jun Yao  Min Zhang
Institution:1. The Second Department of General Surgery, The First Hospital of Lanzhou University, Key Laboratory of Biotherapy and Regenerative Medicine, Gansu Province, The First Clinical Medical College of Lanzhou University, Lanzhou 730000, Gansu, China;2. School of Pharmacy, Lanzhou University, Lanzhou 730020, China;3. Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou 730000, China;4. Department of Chemistry, Lanzhou University, Lanzhou 730000, China;5. Gansu Provincial Hospital, Lanzhou 730000, China
Abstract:N-trans-feruloyloctopamine (FO) isolated from Garlic skin was identified as the primary antioxidant constituents, however, the effect of which on HCC invasion is still unclear. Herein, the FO was synthesized and its antitumor activities were evaluated in HCC cell lines. Cellular functional analyses have revealed that the reformed FO owns strong abilities of inhibiting cell proliferation and invasion in HCC cells. Molecular data have further showed that FO could significantly decrease the phosphorylation levels of Akt and p38 MAPK. In addition, the expression of Slug was inhibited and the level of E-cadherin increased. Molecular docking analysis indicates that the H-bond and hydrophobic interactions were critical for FO and E-cadherin binding, but FO did not seem to act directly on phosphorylated Akt and p38 MAPK. We have thus concluded that reformed FO inhibits cell invasion might be directly through EMT related signals (E-cadherin) and indirectly through PI3K/Akt, p38 MAPK signaling pathways. FO might be a promising drug in HCC treatment and prognosis.
Keywords:AKT  MAPK  E-cadherin  Epithelial to mesenchymal transition (EMT)  Hepatocellular carcinoma
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号